Dr. Reddy's Laboratories Ltd. 500124 shares slid 1.27% to 1,354.20 Indian rupees Friday, on what proved to be an all-around ...

Geode Capital Management LLC increased its position in Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 109.3% ...

DRL also faces headwinds because of increasing competitive intensity in the generic market and exchange rate volatility.

Discover the Dr Reddys Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Shares of Dr. Reddy's Laboratories Ltd. 500124 inched up 0.07% to 1,371.60 Indian rupees Thursday, on what proved to be an ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

The Nifty Pharma index closed on a note on Wednesday. Shares of Dr. Reddy's Laboratories Ltd.(up 1.43 per cent) ended the day ...

Dr Reddy's Laboratories Limited has announced the sale of its step-down wholly owned subsidiary, Dr Reddy's Laboratories ...

Dr. Reddys Laboratories shares rose 4% after Nuvama upgraded its rating to 'buy,' citing proactive strategies to mitigate the ...

The S&P BSE Sensex was down 141.64 points to 78,057.47 at 10:09 am, while the NSE Nifty50 was trading 42.60 points lower at ...

Dr Reddy’s Laboratories Inc., USA, the wholly owned subsidiary of the company, has entered into an agreement for the sale of all the issued and outstanding membership interests in its wholly owned ...

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide.